These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12136904)

  • 1. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
    Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
    J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
    Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
    J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
    Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
    Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.
    Pelletier JP; Boileau C; Brunet J; Boily M; Lajeunesse D; Reboul P; Laufer S; Martel-Pelletier J
    Bone; 2004 Mar; 34(3):527-38. PubMed ID: 15003800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
    Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
    J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway.
    Boileau C; Pelletier JP; Tardif G; Fahmi H; Laufer S; Lavigne M; Martel-Pelletier J
    Ann Rheum Dis; 2005 Jun; 64(6):891-8. PubMed ID: 15498796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
    Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
    Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
    Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
    Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
    Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
    Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
    Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
    Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
    Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.
    Pelletier JP; Boileau C; Boily M; Brunet J; Mineau F; Geng C; Reboul P; Laufer S; Lajeunesse D; Martel-Pelletier J
    Arthritis Res Ther; 2005; 7(5):R1091-102. PubMed ID: 16207326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2.
    Boileau C; Martel-Pelletier J; Caron J; Paré F; Troncy E; Moreau M; Pelletier JP
    Ann Rheum Dis; 2010 Jun; 69(6):1179-84. PubMed ID: 19546097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].
    Hu H; Zhang L; Li B; Zhang Y; Liu X; Tian F; Cheng T; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Dec; 23(12):1474-81. PubMed ID: 20073314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study.
    Fernandes JC; Martel-Pelletier J; Lascau-Coman V; Moldovan F; Jovanovic D; Raynauld JP; Pelletier JP
    J Rheumatol; 1998 Aug; 25(8):1585-94. PubMed ID: 9712105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.